Home › Cancro del polmone non a piccole cellule › New Mexico › Albuquerque
Studi clinici su Cancro del polmone non a piccole cellule a Albuquerque, NM
18 studi su Cancro del polmone non a piccole cellule cercano partecipanti presso sedi a Albuquerque e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
In reclutamentoFase 3
- University of New Mexico Cancer Center, Albuquerque
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
In reclutamentoFase 2/3
- University of New Mexico - Comprehensive Cancer Center, Albuquerque
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
In reclutamentoFase 3
- University of New Mexico Cancer Center, Albuquerque
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
In reclutamentoFase 3
- University of New Mexico Cancer Center, Albuquerque
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
In reclutamentoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
In reclutamentoFase 2
- University of New Mexico, Albuquerque
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
In reclutamentoFase 2
- New Mexico Oncology Hematology Consultants, Ltd, Albuquerque
Prospective External Control Cohort In Patients With Newly Diagnosed Advanced or Metastatic EGFR Mutant Non-Small Cell Lung Cancer
In reclutamentoStudio osservazionale
- New Mexico Oncology Hematology Consultants, Albuquerque
An External Control Arm Study in Non-Small Cell Lung Cancer
In reclutamentoStudio osservazionale
- New Mexico Oncology Hematology Consultants, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
In reclutamentoFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
In reclutamentoFase 3
- Research Site, Albuquerque
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
In reclutamentoFase 3
- University of New Mexico Comprehensive Cancer Center ( Site 0135), Albuquerque
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
In reclutamentoFase 2
- University of New Mexico Cancer Center, Albuquerque
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
In reclutamentoFase 2/3
- University of New Mexico Cancer Center, Albuquerque
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
In reclutamentoStudio osservazionale
- Lovelace Medical Center-Saint Joseph Square, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
- Lovelace Women's Hospital, Albuquerque
- e altri 1
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
In reclutamentoFase 1/2
- Presbyterian Kaseman Hospital (site 208), Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Albuquerque
BostonGene and Exigent Genomic INsight Study
In reclutamentoStudio osservazionale
- New Mexico Cancer Center, Albuquerque
Studi su Cancro del polmone non a piccole cellule in altre città
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Altri studi a Albuquerque
- Cancro al seno17 studi
- Cancro ovarico15 studi
- Cancro (tutti i tipi)14 studi
- Cancro ai polmoni14 studi
- Cancro metastatico12 studi
- Cancro dell'endometrio12 studi
- Diabete di tipo 211 studi
- Malattie cardiovascolari10 studi
- Melanoma9 studi
- Leucemia mieloide acuta9 studi
- Cancro alla prostata9 studi
- Malattia renale cronica8 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.